Ciclosporin (Sandimmun) inj 50 mg per ml, 5 ml ampoule: Hospital supply issue resolved
Due to a surge in demand and a delay in shipping, there was a supply issue affecting ciclosporin injections (Pharmacode: 327921).
18 September 2024
Registered ciclosporin has arrived and been released to wholesalers.
Affected product
This product is used in solid organ transplant and post bone marrow transplant (Graft vs Host) where people cannot take the medicine orally.
- Chemical: Ciclosporin
- Presentation: Inj 50 mg per ml, 5 ml ampoule
- Brand: Sandimmun
- Pharmacode: 327921
- Price: $276.30
- Measure / Qty: per 10
HML listing for ciclosporin(external link)
This issue does not affect any other presentations of ciclosporin.
Alternative product
Novartis, the supplier, brought in stock of the Australian version of the product. It was not Medsafe approved. It needed to be prescribed and given in line with section 29 of the Medicines Act.
Resupplied mid-September 2024
Novartis advises that the shipment has arrived and stock has been released.
Who to contact
If you have questions about this issue, email enquiry@pharmac.govt.nz
Please include as much information as you can about the product (presentation, brand, pharmacode) and who your wholesaler is.
Sign up to our email list for regular emails about supply issues and more(external link)